These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37551126)

  • 1. Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.
    Kwon S; Hyeon JS; Jung Y; Li L; An JN; Kim YC; Yang SH; Kim T; Kim DK; Lim CS; Hwang GS; Lee JP
    Kidney Res Clin Pract; 2023 Jul; 42(4):445-459. PubMed ID: 37551126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine tricarboxylic acid cycle signatures of early-stage diabetic kidney disease.
    Lunyera J; Diamantidis CJ; Bosworth HB; Patel UD; Bain J; Muehlbauer MJ; Ilkayeva O; Nguyen M; Sharma B; Ma JZ; Shah SH; Scialla JJ
    Metabolomics; 2021 Dec; 18(1):5. PubMed ID: 34928443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
    Qian F; Zhao L; Zhang D; Yu M; Zhou W; Jin J
    FEBS Open Bio; 2023 Oct; 13(10):1844-1858. PubMed ID: 37525631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest.
    Jiang JJ; Sham TT; Gu XF; Chan CO; Dong NP; Lim WH; Song GF; Li SM; Mok DK; Ge N
    Aging (Albany NY); 2024 Feb; 16(4):3420-3530. PubMed ID: 38349886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic performance of renal compartment volume and the apparent diffusion coefficient obtained from magnetic resonance imaging in mild, moderate and severe diabetic kidney disease.
    Zhao K; Li S; Liu Y; Li Q; Lin H; Wu Z; Seeliger E; Niendorf T; Liu Z; Wang W
    Quant Imaging Med Surg; 2023 Jun; 13(6):3973-3987. PubMed ID: 37284101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 11. What do we know about biomarkers in diabetic kidney disease?
    Kwiendacz H; Nabrdalik K; Stompór T; Gumprecht J
    Endokrynol Pol; 2020; 71(6):545-550. PubMed ID: 33378070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan.
    Hyeon JS; Jung Y; Lee G; Ha H; Hwang GS
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.
    Niewczas MA; Mathew AV; Croall S; Byun J; Major M; Sabisetti VS; Smiles A; Bonventre JV; Pennathur S; Krolewski AS
    Diabetes Care; 2017 Mar; 40(3):383-390. PubMed ID: 28087576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
    An JN; Hyeon JS; Jung Y; Choi YW; Kim JH; Yang SH; Oh S; Kwon S; Lee SH; Cho JH; Park SH; Ha H; Kim DK; Lee JP; Hwang GS
    Sci Rep; 2019 Oct; 9(1):14707. PubMed ID: 31605028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.
    Titan SM; Venturini G; Padilha K; Goulart AC; Lotufo PA; Bensenor IJ; Krieger JE; Thadhani RI; Rhee EP; Pereira AC
    PLoS One; 2019; 14(3):e0213764. PubMed ID: 30883578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.
    Zhang Q; Zhang Y; Zeng L; Chen G; Zhang L; Liu M; Sheng H; Hu X; Su J; Zhang D; Lu F; Liu X; Zhang L
    Front Pharmacol; 2021; 12():757508. PubMed ID: 34899312
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
    Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biomarkers for prognosticating diabetic kidney disease progression.
    Swaminathan SM; Rao IR; Shenoy SV; Prabhu AR; Mohan PB; Rangaswamy D; Bhojaraja MV; Nagri SK; Nagaraju SP
    Int Urol Nephrol; 2023 Apr; 55(4):913-928. PubMed ID: 36271990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.